Company Presentation • 05 Nov 2024 21:30
Company Presentation • 27 Oct 2024 03:30
Company Presentation • 08 Aug 2024 20:00
Company Presentation • 01 Aug 2024 20:30
Company Presentation • 27 Jun 2018 02:00
ENTITY
Apellis Pharmaceuticals (APLS US)
Apellis Pharmaceuticals (APLS US)
36
Analysis
Health Care • United States
Apellis Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. Apellis Pharmaceuticals serves clients worldwide.
more
x